Clinical Trial Update: Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema [Phase 2]

View source ↗

Summary

Phase 2 pilot study of tetomilast in chronic obstructive pulmonary disease with emphysema was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tetomilast (tetomilast)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: TERMINATED | Results posted: 2017-04-17